Interestingly, the blockade of YAP1 and TEAD coactivator transcriptional activity using CA3 (CIL56) during the recovery phase of AKI was proposed as a promising therapeutic approach to prevent CKD [86]. Here, YAP1 is linked to acute kidney injury.